4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0000950170-25-113245
Options or other derivatives
- Chief Financial Officer acquired 600,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sendek Joel · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-04 | Grant or award : show line 1 in the form Stock option (right to buy) | +600,000 | 600,000 | D |
Loading xslF345X05/ownership.xml…